Brief: Bio-Path Holdings Reports Third Quarter 2022 Financial Results
Nov 15 (Reuters) - Bio Path Holdings Inc BPTH.O :
* BIO-PATH HOLDINGS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* QTRLY NET LOSS OF $0.49 PER SHARE
* AS OF SEPTEMBER 30, 2022, COMPANY HAD CASH OF $13.7
MILLION,
COMPARED TO $23.8 MILLION AT DECEMBER 31, 2021
Source text for Eikon: ID:nGNXbN6D00
Further company coverage: BPTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Path Holdings
See all newsBrief: Bio-Path Holdings Seeks Financing For Turnaround & Strategic Actions
Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia